Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
J Allergy Clin Immunol ; 78(2): 353-7, 1986 Aug.
Article in English | MEDLINE | ID: mdl-3734288

ABSTRACT

A 36-year-old white woman with a 20-year history of cutaneous, respiratory, and cardiovascular symptoms triggered by physical activity and by exposure to either heat or cold was evaluated. A routine evaluation for the cause of her condition was positive only for certain physical factors. Cutaneous testing for dermatographism, ice-cube challenge, and exposure to ultraviolet A and ultraviolet B light were negative. A methacholine skin test was positive. Sitting in a cold room (4 degrees C) induced micropapular wheals on exposed areas similar to those classically associated with cholinergic urticaria. Placing both feet in warm water (44 degrees C) induced similar but more intense cutaneous lesions at sites not exposed to heat, light headedness, and severe asthma. Exercise for 10 minutes caused confluent and punctate urticarial lesions. Simultaneous measurement of plasma histamine during cold and heat challenges revealed increases paralleling the course of symptoms. Repeat challenge with cold, heat, and exercise after beginning treatment with both H1 and H2 histamine antagonists resulted in marked reduction in symptoms; however, significant rises in plasma histamines were still noted.


Subject(s)
Urticaria/etiology , Adult , Cholinergic Fibers/physiopathology , Cimetidine/therapeutic use , Cold Temperature , Doxepin/therapeutic use , Drug Therapy, Combination , Female , Hot Temperature , Humans , Metaproterenol/therapeutic use , Physical Exertion , Theophylline/therapeutic use , Urticaria/drug therapy , Urticaria/physiopathology
3.
Dermatol Clin ; 3(1): 85-95, 1985 Jan.
Article in English | MEDLINE | ID: mdl-2868818

ABSTRACT

Angioedema is characterized by a well-demarcated swelling on the skin, oropharyngolaryngeal tissue, or the gastrointestinal wall. Underlying mechanisms may include IgE-mediated reactions, complement activation, inhibition of the cyclo-oxygenase pathway of arachidonic acid metabolism, direct release of mediators from mast cells, and activation of the kinin-forming system. Foods, drugs, inhalants, insect bites, blood transfusion, collagen vascular disease, infections, physical factors, neoplasms, and hereditary factors can cause angioedema through one or more of these mechanisms. Chronic angioedema lasts more than 6 weeks or recurs during this period. Acute angioedema is a self-limited disorder and resolves spontaneously, or with simple therapy, in several days; the patient rarely requires a complete work-up. Chronic angioedema may necessitate a detailed history, physical examination, and limited clinical or laboratory tests to exclude serious underlying illnesses. The H1 antihistamines are used for the treatment of both acute and chronic angioedema. An H2 antihistamine, a second H1 antihistamine, or rarely even a low dose of corticosteroid may be added to the regimen if H1 antihistamine alone fails to control chronic angioedema. Hereditary angioedema is an autosomal dominant disease that is caused by C1INH deficiency. In patients with this disorder, swelling of the lip, pharynx, and extremities may follow trauma to soft tissue. Other clinical manifestations include abdominal pain, nausea, vomiting, and suffocation because of laryngeal swelling. Diagnosis can be confirmed by the finding of low levels of C4 and C2 and the absence of nonfunction of C1INH. Androgens reverse the biochemical defects.


Subject(s)
Angioedema/therapy , Angioedema/etiology , Angioedema/genetics , Angioedema/physiopathology , Arachidonic Acid , Arachidonic Acids/metabolism , Biomechanical Phenomena , Complement Activation , Epinephrine/therapeutic use , Histamine H1 Antagonists/therapeutic use , Histamine H2 Antagonists/therapeutic use , Humans , Hydroxyzine/therapeutic use , Immunoglobulin E/physiology , Mast Cells/drug effects
4.
J Immunol ; 134(1): 541-7, 1985 Jan.
Article in English | MEDLINE | ID: mdl-2578053

ABSTRACT

Basophil degranulation probably plays a significant role in the pathogenesis of different hypersensitivity reactions. These cells can be stimulated to secrete lysosomal histamine in vitro in response to various secretagogues. We compared the effects of drugs, modulating arachidonic acid (AA) metabolism, on histamine release (HR) from human basophils stimulated by anti-IgE antibody or C5a anaphylatoxin. Leukocytes from normal donors were preincubated with drug for 15 min at 22 degrees C, followed by the addition of C5a or anti-IgE for 30 min at 37 degrees C. Bromophenacyl bromide, an inhibitor of AA formation by phospholipase, blocked the effects of C5a and anti-IgE (greater than or equal to 3.3 X 10(-6) M, p less than 0.05 and p less than 0.01, respectively). 3-Amino-1-(3-trifluoromethylphenyl)-2-pyrazoline hydrochloride (BW755C, greater than or equal to 3.3 X 10(-5) M) and 5, 8, 11, 14-eicosatetraynoic acid (greater than or equal to 3.3 X 10(-4) M), known inhibitors of both cyclooxygenase (COX) and lipoxygenase (LPX) pathways of AA metabolism, blocked both C5a- and anti-IgE-induced HR (p less than 0.01). Nordihydroguaiaretic acid, an inhibitor of LPX, decreased HR induced by anti-IgE (greater than or equal to 3.3 X 10(-6) M, p less than 0.01) and allergens, but reduced C5a-initiated HR only at a higher concentration (greater than or equal to 7 X 10(-5) M, p less than 0.01). Indomethacin (INDO), an inhibitor of COX, significantly reduced HR caused by C5a (greater than or equal to 3.3 X 10(-8) M, p less than 0.01) and its degradation product C5adesArg, but had no effect or caused slight enhancement of HR initiated by anti-IgE. We confirmed that INDO augments allergen-induced HR. Our findings suggest that there are basic differences in the regulation of C5a- and IgE-mediated basophil degranulation.


Subject(s)
Arachidonic Acids/metabolism , Basophils/immunology , Complement C5/immunology , Histamine Release , Immunoglobulin E/immunology , 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine , 5,8,11,14-Eicosatetraynoic Acid/pharmacology , Anti-Inflammatory Agents/pharmacology , Arachidonic Acid , Basophils/drug effects , Basophils/metabolism , Catechols/pharmacology , Complement C5a , Histamine Release/drug effects , Humans , Indomethacin/pharmacology , Masoprocol , Phospholipases/pharmacology , Pyrazoles/pharmacology
5.
Ann Allergy ; 54(1): 35-8, 1985 Jan.
Article in English | MEDLINE | ID: mdl-2578262

ABSTRACT

An 18-year-old hispanic male, his two brothers, father, two paternal uncles, and paternal grandfather experienced cutaneous and cardiorespiratory symptoms during vigorous exercise beginning at about 10 years of age. The propositus was challenged by running to exhaustion and by immersion in hot water. In neither case were allergic signs or symptoms noted; however, plasma histamine rose from undetectable levels to 1.0 and 3.7 ng/ml, respectively. Furthermore, C2 and C5 were significantly reduced and fell during exercise.


Subject(s)
Anaphylaxis/etiology , Physical Exertion , Adolescent , Adult , Anaphylaxis/genetics , Complement Activation , Histamine/blood , Histamine Release , Humans , Male , Mast Cells/metabolism , Pedigree
6.
J Allergy Clin Immunol ; 73(6): 842-5, 1984 Jun.
Article in English | MEDLINE | ID: mdl-6725793

ABSTRACT

We have studied a 50-year-old white man with chronic urticaria and angioedema who has responded to treatment with cimetidine alone for over 2 yr. In a double-blind, placebo-controlled study, cimetidine alone was at least as effective as chlorpheniramine in relief of urticaria and angioedema. Additionally, cimetidine significantly inhibited (p less than 0.01) the wheal response to histamine when it was compared to placebo. The inhibition of wheal response to histamine by cimetidine was significantly higher (p less than 0.05) than chlorpheniramine. The presence of predominantly H2- rather than H1-histamine receptors in the cutaneous blood vessels may be responsible for the therapeutic effects of cimetidine in this patient.


Subject(s)
Angioedema/drug therapy , Cimetidine/therapeutic use , Urticaria/drug therapy , Chlorpheniramine/therapeutic use , Double-Blind Method , Drug Therapy, Combination , Histamine/immunology , Humans , Intradermal Tests , Male , Middle Aged , Pruritus/drug therapy , Receptors, Histamine H2/immunology
7.
J Allergy Clin Immunol ; 73(5 Pt 1): 596-9, 1984 May.
Article in English | MEDLINE | ID: mdl-6371103

ABSTRACT

A prospective study was performed to determine the incidence of antinuclear antibodies in 214 normal pregnant women and in 50 age-matched controls. Serum samples of 23 pregnant women (10.7%) yielded positive results (1 + or more at a dilution of 1:20) in contrast with only one sample (2%) in the control group (p less than 0.05). Of the pregnant women found to be positive, five (9.2%) were in the second trimester, and 18 (13.4%) were in the last trimester. Only two also had positive anti-DNA antibodies. A review of their hospital records disclosed no reason to suspect systemic lupus erythematosus or other rheumatologic diseases nor any significant increase in neonatal morbidity of their infants. We conclude that the incidence of antinuclear antibodies in pregnant women is significantly higher than in nonpregnant women and that the finding probably does not correlate with any adverse clinical effect.


Subject(s)
Antibodies, Antinuclear/analysis , Blood , Pregnancy , Adolescent , Adult , Female , Fluorescent Antibody Technique , Humans , Immunity, Cellular , Prospective Studies
8.
Oral Surg Oral Med Oral Pathol ; 57(4): 374-8, 1984 Apr.
Article in English | MEDLINE | ID: mdl-6584831

ABSTRACT

This report describes a case of osteomyelitis that did not respond to routine hyperbaric oxygen, surgical debridement, and intravenous antibiotics. The multiple sites of the osteomyelitis, the presence of skin lesions, and the unusual organism (Corynebacterium group JK, L form) that was isolated indicated that the patient might have an immunodeficiency, but none could be identified.


Subject(s)
Corynebacterium Infections/pathology , Mandibular Diseases/pathology , Osteomyelitis/pathology , Adult , Corynebacterium/classification , Corynebacterium/isolation & purification , Humans , Male , Mandibular Diseases/microbiology , Osteomyelitis/microbiology , Recurrence
9.
Clin Exp Rheumatol ; 2(1): 41-6, 1984.
Article in English | MEDLINE | ID: mdl-6241858

ABSTRACT

Although mild peripheral eosinophilia is a common finding in Sjögren's syndrome (SS), severe eosinophilia with a clinical picture simulating hypereosinophilic syndrome is extremely rare. We report a 24 year old male with SS presenting with swelling of the parotid glands, redness and irritation of the eyes, polyarthralgias and polyarthritis, weight loss, exertional dyspnea, malaise, erythematous and urticarial skin lesions and enlarged lymph nodes. Laboratory tests showed hypereosinophilia (34%, total 3800/mm3), lymphopenia (2%, total 220/mm3), a positive RA factor (1:2560) and decreased C3 and C4. Biopsy of an enlarged submaxillary gland was consistent with SS. A Schirmer test showed decreased tear production. Salivary glands showed a marked decrease in uptake of radioactive (Tc99) dye. Circulating immune complexes (CIC) were markedly elevated by both C1q binding and Raji cell assays. T-cell subsets showed OKT3 = 63%, OKT4 = 32% and OKT8 = 16%. "Histamine trap" in vivo test for CIC revealed fluorescence in upper dermal blood vessels with IgM, C1q, C3 and fibrin. Biopsies of the liver, bone marrow and skin revealed eosinophilic infiltration. A notable response to therapy with high doses of corticosteroids was seen with recurrence of symptoms and laboratory abnormalities after the therapy was stopped. In conclusion, we present a case of SS which is remarkable for the age and sex of the patient, extreme hypereosinophilia, marked lymphopenia, and CIC.


Subject(s)
Eosinophilia/etiology , Immune Complex Diseases/etiology , Lymphopenia/etiology , Sjogren's Syndrome/complications , Adult , Antibodies, Monoclonal , Biopsy , Diagnosis, Differential , Eosinophilia/pathology , Humans , Lymphopenia/pathology , Male , Microscopy, Fluorescence , Parotid Gland/pathology , Prednisone/therapeutic use , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/drug therapy , Sjogren's Syndrome/pathology , Skin/pathology
10.
J Allergy Clin Immunol ; 68(2): 112-8, 1981 Aug.
Article in English | MEDLINE | ID: mdl-6166648

ABSTRACT

IgG "blocking" antibodies were measured in patients receiving insect venom immunotherapy. The enzyme-linked immunosorbent assay (ELISA) described herein was found to be sensitive and reproducible. Results with ELISA correlated well with values obtained with a radioimmunoassay and with inhibition of the release of histamine from sensitive basophils. Also, specific antibody titers against phospholipase A and whole bee venom were correlated. Serial determinations of venom-specific IgG antibodies were made in 17 patients receiving Polistes wasp or bee venom immunotherapy. The majority of patients showed a rise in IgG antibodies, which peaked after administration of approximately 500 micrograms of venom. Only one out of 13 of these venom-treated patients had allergic symptoms after an insect sting while on maintenance therapy.


Subject(s)
Bee Venoms/immunology , Immunoglobulin G/biosynthesis , Wasp Venoms/immunology , Bee Venoms/therapeutic use , Dose-Response Relationship, Immunologic , Enzyme-Linked Immunosorbent Assay , Histamine Release , Humans , Insect Bites and Stings/immunology , Phospholipases A/immunology , Radioimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL